About eGenesiseGenesis is a clinical-stage biotechnology company developing human-compatible engineered organs to address the severe global organ shortage. The Company’s proprietary genome engineering platform enables extensive, multiplex gene edits to remove key biological barriers, add protective human transgenes, and inactivate endogenous retroviruses. EGEN-2784, a genetically engineered porcine kidney, is the Company’s lead program and is currently being evaluated in a multi-patient Expanded Access study at MGH. eGenesis is headquartered in Cambridge, MA.
We are seeking a reliable member to join the eGenesis Farm Operations team and assist in all farm activities including operating large equipment, hay production, landscaping, and basic animal care of swine. The right individual will have experience working with large animals, farm equipment, and must be able to perform maintenance on equipment and buildings. Experience with hand tools and power tools is required. This position requires working a rotating weekend and holiday schedule. The right individual must be detail-oriented with strong communication skills and the ability to work as a team and individually. This position requires physical demands such as climbing, stooping, crouching, sitting on equipment such as lawnmowers and tractors for extended periods, and handling/moving swine throughout the facilities.
While performing the duties of this job, the employee is regularly required to work in different environments, including farm, shop, office, laboratory, and animal husbandry environments in varying weather conditions. The employee frequently is required to be walking, stooping, climbing, and crouching. Specific vision abilities required by this job include close vision, distance vision, color vision, peripheral vision, depth perception and ability to adjust to focus.

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation.
eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.